2022-08-01 06650404 2023-07-31 06650404 2022-08-01 2023-07-31 06650404 2022-07-31 06650404 2021-08-01 2022-07-31 06650404 uk-core:WithinOneYear uk-bus:Original 2022-07-31 06650404 uk-core:WithinOneYear uk-bus:Original 2023-07-31 06650404 uk-core:ShareCapital uk-bus:Original 2023-07-31 06650404 uk-core:ShareCapital uk-bus:Original 2022-07-31 06650404 uk-core:RetainedEarningsAccumulatedLosses uk-bus:Original 2023-07-31 06650404 uk-core:RetainedEarningsAccumulatedLosses uk-bus:Original 2022-07-31 06650404 uk-bus:Director1 uk-bus:Original 2022-08-01 2023-07-31 06650404 uk-core:PlantMachinery uk-bus:Original 2022-08-01 2023-07-31 06650404 uk-core:ToolsEquipment uk-bus:Original 2022-08-01 2023-07-31 06650404 uk-core:ToolsEquipment uk-bus:Original 2022-07-31 06650404 uk-core:PlantMachinery uk-bus:Original 2022-07-31 06650404 uk-core:PlantMachinery uk-bus:Original 2023-07-31 06650404 uk-core:ToolsEquipment uk-bus:Original 2023-07-31 iso4217:GBP xbrli:pure 06650404 uk-bus:AuditExemptWithAccountantsReport uk-bus:Original 2022-08-01 2023-07-31 06650404 uk-bus:FRS102 uk-bus:Original 2022-08-01 2023-07-31 06650404 uk-bus:FilletedAccounts uk-bus:Original 2022-08-01 2023-07-31 06650404 uk-bus:PrivateLimitedCompanyLtd uk-bus:Original 2022-08-01 2023-07-31
Doctor Lowry Limited
Registered Number:06650404
For the year ended 31 July 2023
England and Wales
Unaudited Financial Statements
2
For the year ended 31 July 2023
Doctor Lowry Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
06650404
As at 31 July 2023
Doctor Lowry Limited
Statement of Financial Position
£
£
2022
2023
Notes
Fixed assets
Property, plant and equipment
(139)
-
2
(139)
-
Trade and other payables: amounts falling due within one year
(26,949)
(27,630)
3
(26,949)
(27,630)
Net current liabilities
Total assets less current liabilities
(27,769)
(26,949)
(27,769)
Net liabilities
(26,949)
Capital and reserves
Called up share capital
1
1
Retained earnings
(27,770)
(26,950)
(27,769)
(26,949)
Shareholders' funds
For the year ended 31 July 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Dr R J Lowry Director
These financial statements were approved and authorised for issue by the Board on 07 November 2023 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 31 July 2023
Doctor Lowry Limited
Notes to the Financial Statements
Statutory Information
Doctor Lowry Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number
06650404.
Registered address:
35 King Edward Road
Tynemouth
Tyne and Wear
NE20 2RW
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
The financial statements have been prepared under the historical costs convention.
The director believes the preparation of the accounts on a going concern basis is appropriate. He has given confirmation that
financial support will be provided to enable the company to meet its ongoing financial liabilities. The policy was in effect for
the financial year and will remain in effect for a period ending no sooner than 12 months from the date the accounts are
approved by the board.
Revenue recognition
Turnover represents amounts receivable for services. Amounts receivable for services performed over time are based upon the stage of completion of the services performed.
Property, plant and equipment
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and machinery
25% Straight line
33% Straight line
Computer equipment
2. Property, plant and equipment
Total
Computer
equipment
Plant and
machinery
£
£
£
Cost or valuation
At 01 August 2022
15,954
15,676
278
701
701
-
Additions
At 31 July 2023
278
16,377
16,655
Provision for depreciation and impairment
At 01 August 2022
15,954
15,676
278
Charge for year
840
840
-
At 31 July 2023
16,794
16,516
278
At 31 July 2023
Net book value
-
(139)
(139)
At 31 July 2022
-
-
-
2 of 3
5
For the year ended 31 July 2023
Doctor Lowry Limited
Notes to the Financial Statements Continued
3. Trade and other payables: amounts falling due within one year
2022
2023
£
£
Trade creditors
1
-
Other creditors
27,629
26,949
27,630
26,949
4. Average number of persons employed
During the year the average number of employees was 1.
5. Transition to FRS 102
The principal accounting polices applied in the preparation of the financial statements are set out above. These policies have
been consistently applied to all the years presented, unless otherwise stated. No changes have arisen as a result of the
transition to Section 1A of Financial Reporting Standard 102.
3 of 3